These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11820065)

  • 21. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial).
    Ryuzaki M; Nakamoto H; Nishida E; Sone M; Nakajima S; Yoshimoto M; Suzuki Y; Itagaki K
    J Hypertens; 2007 Nov; 25(11):2352-8. PubMed ID: 17921832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Emergency checklist in hypertensive crisis].
    Füessl HS
    MMW Fortschr Med; 2006 Jun; 148(25):49. PubMed ID: 16859163
    [No Abstract]   [Full Text] [Related]  

  • 23. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C; Coca A
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barnidipine: a step towards safer blood pressure control?
    Birkenhäger WH
    Int J Clin Pract Suppl; 2000 Nov; (114):1. PubMed ID: 11221288
    [No Abstract]   [Full Text] [Related]  

  • 25. Barnidipine: a new calcium channel blocker for hypertension treatment.
    Liau CS
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):207-13. PubMed ID: 15853594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension therapy with beta blocker plus diuretic. "We are at the point of leaving behind an era"].
    Dahlöf B
    MMW Fortschr Med; 2005 Mar; 147(12):8. PubMed ID: 15832781
    [No Abstract]   [Full Text] [Related]  

  • 27. [ALLHAT--remaining questions await answers].
    Nilsson PM
    Lakartidningen; 2004 Jan; 101(3):220, 223; discussion 224-7. PubMed ID: 14763096
    [No Abstract]   [Full Text] [Related]  

  • 28. Treating high blood pressure in Africans with type 2 diabetes.
    Okoro EO; Oyejola BA
    Ethn Dis; 2004; 14(1):160-1. PubMed ID: 15002939
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials.
    Fournier A; Messerli FH; Achard JM; Fernandez L
    J Am Coll Cardiol; 2004 Apr; 43(8):1343-7. PubMed ID: 15093864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K; van der Tuin J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting it close. It's the right dose and the right drug--how can it be too much?
    Karch AM; Karch FE
    Am J Nurs; 2000 Jan; 100(1):23. PubMed ID: 10705835
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study.
    Saito I; Fujikawa K; Saruta T;
    Hypertens Res; 2008 Jul; 31(7):1399-405. PubMed ID: 18957811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of complicated and uncomplicated hypertension with nifedipine in Palestine.
    Sweileh WM
    Saudi Med J; 2005 Jan; 26(1):78-83. PubMed ID: 15756358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The ACCOMPLISH trial: are results really unexpected?].
    Waeber B; Feihl F
    Rev Med Suisse; 2009 Jan; 5(185):25-8. PubMed ID: 19216321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intima-media thickness in hypertensive patients. Calcium blockers controls atherosclerosis].
    MMW Fortschr Med; 2002 Jan; 144(1-2):66-7. PubMed ID: 11847890
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 38. [Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
    Palma-Aguirre JA; Campos-Lara M; Chávez-Negrete A
    Gac Med Mex; 2002; 138(4):381-3. PubMed ID: 12200885
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
    Thompson AE; Pope JE
    Rheumatology (Oxford); 2005 Feb; 44(2):145-50. PubMed ID: 15546967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws.
    Penston J
    BMJ; 2005 Jan; 330(7483):145; author reply 146. PubMed ID: 15649934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.